Table S3 from Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER–Medicare Analysis

MLA

Asad Umar, et al. Table S3 from Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER–Medicare Analysis. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1940-6207.22533247.

APA

Asad Umar, Ellen Richmond, Matthew Chaloux, & Holli A. Loomans-Kropp. (2023). Table S3 from Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER–Medicare Analysis. https://doi.org/10.1158/1940-6207.22533247

Chicago

Asad Umar, Ellen Richmond, Matthew Chaloux, and Holli A. Loomans-Kropp. 2023. “Table S3 from Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER–Medicare Analysis,” April. doi:10.1158/1940-6207.22533247.